Timing is key in reducing the risk of developing vision loss or blindness.
Digital edition: January 2022
Test your knowledge!
Expected findings in follow-up, management, and potential complications.
Expand your business by administering injectable treatments.
A review of monitoring guidelines, risk assessment, and treatment algorithms.
Current findings review risks, benefits, and performance.
With its anti-infective, anti-inflammatory, and regenerative properties, this versatile therapeutic should be in your toolbox.
A 68-year-old White woman was referred for persistent keratitis OS and failure on multiple medications. Find out her official diagnosis and treatment plan.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AOA 2026: Burnout in optometry on par with health care industry trends
2
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
3
PCC – Reducing Treatment Burden in Retinal Disease Care with Extended-Duration Anti-VEGF Therapies
4
AOA 2026: Integrating AI into everyday eye care practice
5